Cihui Yan

1.8k total citations
33 papers, 1.3k citations indexed

About

Cihui Yan is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Cihui Yan has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Cihui Yan's work include Cancer Immunotherapy and Biomarkers (14 papers), Esophageal Cancer Research and Treatment (11 papers) and CAR-T cell therapy research (7 papers). Cihui Yan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Esophageal Cancer Research and Treatment (11 papers) and CAR-T cell therapy research (7 papers). Cihui Yan collaborates with scholars based in China, United States and United Kingdom. Cihui Yan's co-authors include Xiubao Ren, Jinpu Yu, Yan Fan, Feng Wei, Hui Li, Hua Zhao, Peng Zhang, Yue Wang, Qian Sun and Yan Fang and has published in prestigious journals such as The Journal of Immunology, Biomaterials and Clinical Cancer Research.

In The Last Decade

Cihui Yan

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cihui Yan China 17 597 591 438 225 175 33 1.3k
Mario Di Matteo Belgium 15 481 0.8× 803 1.4× 745 1.7× 335 1.5× 80 0.5× 20 1.6k
Maria L. Henriksson Sweden 15 757 1.3× 548 0.9× 503 1.1× 182 0.8× 113 0.6× 17 1.4k
Eva Van Overmeire Belgium 16 767 1.3× 582 1.0× 1.3k 3.0× 233 1.0× 131 0.7× 20 1.9k
Simeon Santourlidis Germany 24 238 0.4× 1.0k 1.8× 468 1.1× 310 1.4× 87 0.5× 53 1.7k
Pedro Barcellos‐de‐Souza Brazil 13 536 0.9× 504 0.9× 377 0.9× 258 1.1× 82 0.5× 14 1.1k
Upal Basu-Roy United States 12 310 0.5× 708 1.2× 212 0.5× 252 1.1× 74 0.4× 13 1.3k
Douglas B. Stairs United States 19 573 1.0× 980 1.7× 151 0.3× 269 1.2× 370 2.1× 40 1.6k
Jan van Riggelen United States 17 483 0.8× 1.3k 2.2× 201 0.5× 333 1.5× 55 0.3× 20 1.7k
Meng Duan China 22 452 0.8× 589 1.0× 452 1.0× 307 1.4× 190 1.1× 42 1.4k
Ningning Niu China 16 252 0.4× 717 1.2× 161 0.4× 178 0.8× 153 0.9× 34 1.1k

Countries citing papers authored by Cihui Yan

Since Specialization
Citations

This map shows the geographic impact of Cihui Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cihui Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cihui Yan more than expected).

Fields of papers citing papers by Cihui Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cihui Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cihui Yan. The network helps show where Cihui Yan may publish in the future.

Co-authorship network of co-authors of Cihui Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Cihui Yan. A scholar is included among the top collaborators of Cihui Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cihui Yan. Cihui Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Zhao, Gang, Xi Chen, Jie Dong, et al.. (2024). Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies. Cancer Letters. 601. 217178–217178. 7 indexed citations
4.
Feng, Huijing, Guo‐Bin Ding, Cihui Yan, et al.. (2023). TP53 Exon 5 Mutation Indicates Poor Progression-Free Survival for Patients with Stage IV NSCLC. Frontiers in Bioscience-Landmark. 28(7). 147–147. 3 indexed citations
5.
Yan, Cihui, Xiaoxue Ma, Gang Zhao, et al.. (2023). Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer. Frontiers in Immunology. 14. 1138054–1138054. 11 indexed citations
6.
Hui, Zhenzhen, Jiali Zhang, Xiaoling Li, et al.. (2022). Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC). Cell Death and Disease. 13(7). 607–607. 39 indexed citations
8.
Ma, Xiaoxue, Xiaoying Wei, Gang Zhao, et al.. (2022). Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade. Frontiers in Immunology. 12. 786429–786429. 28 indexed citations
9.
Chen, Xi, Wencheng Zhang, Dong Qian, et al.. (2019). Chemoradiotherapy-Induced CD4+ and CD8+ T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 9. 73–73. 15 indexed citations
10.
Yan, Cihui, Yan Fan, Yang An, et al.. (2019). Memory stem T cells generated by Wnt signaling from blood of human renal clear cell carcinoma patients. Cancer Biology and Medicine. 16(1). 109–109. 18 indexed citations
11.
Zhang, Wencheng, Qingsong Pang, Cihui Yan, et al.. (2017). Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma. OncoTargets and Therapy. Volume 10. 763–771. 36 indexed citations
12.
Liu, Liang, Lin Zhang, Lin Yang, et al.. (2017). Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells. Frontiers in Immunology. 8. 404–404. 81 indexed citations
13.
Zheng, Hong, Weipeng Zhao, Cihui Yan, et al.. (2016). HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma. Clinical Cancer Research. 22(16). 4119–4132. 264 indexed citations
14.
Yan, Cihui, Wenwen Yu, Feng Wei, et al.. (2016). Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects. Tumor Biology. 37(6). 8425–8435. 28 indexed citations
15.
Yang, Fan, Hao Jin, Jian Wang, et al.. (2016). Adoptive Cellular Therapy (ACT) for Cancer Treatment. Advances in experimental medicine and biology. 909. 169–239. 16 indexed citations
16.
Wang, Yang, Xujie Gao, Feng Wei, et al.. (2014). The hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evidence from 48 case–control studies. Tumor Biology. 36(2). 1029–1038. 12 indexed citations
17.
Wang, Yang, Xujie Gao, Feng Wei, et al.. (2013). Diagnostic and prognostic value of circulating miR-21 for cancer: A systematic review and meta-analysis. Gene. 533(1). 389–397. 131 indexed citations
18.
Yuan, Xiangfei, Hongwei Peng, Yahui Ding, et al.. (2012). Gene therapy in B-NHL cell line using adenovirus-mediated transfer of secretable trimeric TRAIL gene expression driven by CD20 promoter. Experimental Hematology. 41(3). 221–230. 4 indexed citations
19.
Yan, Cihui, Yaping Yang, Zheng‐Hong Qin, et al.. (2007). Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells. Acta Pharmacologica Sinica. 28(4). 540–548. 59 indexed citations
20.
Yan, Cihui, Zhong‐Qin Liang, Zhen‐Lun Gu, et al.. (2006). Contributions of autophagic and apoptotic mechanisms to CrTX-induced death of K562 cells. Toxicon. 47(5). 521–530. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026